Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.46 |
| ▸ | TUBB | P07437 | 1/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5519899 | 0.84 | IDO1 (0.50) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL18239234 | 0.83 | PYCR1 (0.46) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL10539816 | 0.80 | CA1 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL827300 | 0.80 | AOC3 (0.49) | IDO1CA1CA2ALDH1A1SMN1; SMN2 | |
| SCHEMBL11202551 | 0.80 | CA1 (0.44) | IDO1CA1CA2AGXTTAAR1 | |
| SCHEMBL7594444 | 0.79 | SLC6A4 (0.48) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL7673581 | 0.79 | IDO1 (0.50) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL11432184 | 0.78 | BMP1 (0.49) | — | |
| SCHEMBL827804 | 0.77 | TDP1 (0.49) | LTA4HALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL20892218 | 0.76 | NR1D1 (0.42) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112481224-A | Baeyer-Villiger monooxygenase and application thereof | 江南大学 | 2021-03-12 | — | — | CN | claimed |
| CN-119685854-A | Catalyst for preparing sulfone, preparation method thereof and application of catalyst in preparing sulfone by electrocatalytic oxidation of sulfoxide | 齐鲁工业大学(山东省科学院) | 2025-03-25 | — | — | CN | disclosed |
| CN-113304775-B | Graphene oxide supported molybdenum catalyst with surface chemically grafted, and preparation and application thereof | 沈阳药科大学 | 2023-05-26 | — | — | CN | disclosed |
| CN-107983408-B | Method for preparing sulfoxide catalyst and selectively preparing sulfoxide compound by using sulfoxide catalyst | 三峡大学 | 2021-05-18 | — | — | CN | disclosed |
| CN-112481224-A | Baeyer-Villiger monooxygenase and application thereof | 江南大学 | 2021-03-12 | — | — | CN | disclosed |
| CN-109485587-B | Method for preparing sulfoxide compound by one-step reaction of benzyl chloride compound and thiophenol under metal-free condition | 陕西师范大学 | 2020-10-16 | — | — | CN | disclosed |
| CN-107033162-B | Preparation of 7-phenylacetamide-3-chloromethyl cephalosporanic acid p-methoxybenzyl ester | 湖北凌晟药业有限公司 | 2020-05-01 | — | — | CN | disclosed |
| CN-109485587-A | The method that benzyl chlorides chemical compound and thiophenol prepare sulfoxide compound in no metal condition next step reaction | 陕西师范大学 | 2019-03-19 | — | — | CN | disclosed |
| US-8367871-B2 | Process for production of optically active sulfoxide compound using iron-salan complex catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20100094037-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE SULFOXIDE COMPOUND USING IRON-SALAN COMPLEX CATALYST | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-0859770-A4 | — | — | 1998-10-07 | — | — | EP | disclosed |
| EP-0859770-A1 | PROCESS FOR THE SYNTHESIS OF BENZO b]THIOPHENES | ELI LILLY AND COMPANY (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1996040676-A1 | PROCESS FOR THE SYNTHESIS OF BENZO[b]THIOPHENES | ELI LILLY AND COMPANY (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0089330-B1 | PREPARATION OF SUBSTITUTED BENZYLIC HALIDES | MONSANTO COMPANY (US) | 1987-04-22 | — | — | EP | disclosed |
| US-4540522-A | HALOGENATING A SUBSTITUTED ALKYL BENZYL SULFOXIDE | MONSANTO COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0089330-A2 | Preparation of substituted benzylic halides | MONSANTO COMPANY (US) | 1983-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094037-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE SULFOXIDE COMPOUND USING IRON-SALAN COMPLEX CATALYST | SCLY, SFXN1, SQOR | IDO1 358/4885CA12 1912/4885CA1 2155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.